학술논문
Safety and utility of indwelling pleural catheters in lung transplant recipients.
Document Type
Article
Author
Trindade, Anil J.; Lentz, Robert J.; Gannon, Whitney D.; Rickman, Otis B.; Shojaee, Samira; Vandervest, Katherine; Schwartz, Gary; Li, Gloria W.; Kumar, Anupam; Garcha, Puneet S.; Seeley, Eric J.; Gesthalter, Yaron B.; Mueller, Stephanie; Egan, John P.; DeMaio, Andrew J.; Yarmus, Lonny B.; Josan, Enambir S.; Pannu, Jasleen K.; Wayne, Max T.; DeCardenas, Jose L.
Source
Subject
*LUNG transplantation
*IMPLANTABLE catheters
*PLEURODESIS
*PLEURAL effusions
*CRITICALLY ill
*EMPYEMA
*HOMOGRAFTS
*
*
*
*
*
*
Language
ISSN
0902-0063
Abstract
Introduction: The safety and efficacy of indwelling pleural catheters (IPCs) in lung allograft recipients is under‐reported. Methods: We performed a multicenter, retrospective analysis between 1/1/2010 and 6/1/2022 of consecutive IPCs placed in lung transplant recipients. Outcomes included incidence of infectious and non‐infectious complications and rate of auto‐pleurodesis. Results: Seventy‐one IPCs placed in 61 lung transplant patients at eight centers were included. The most common indication for IPC placement was recurrent post‐operative effusion. IPCs were placed at a median of 59 days (IQR 40–203) post‐transplant and remained for 43 days (IQR 25‐88). There was a total of eight (11%) complications. Infection occurred in five patients (7%); four had empyema and one had a catheter tract infection. IPCs did not cause death or critical illness in our cohort. Auto‐pleurodesis leading to the removal of the IPC occurred in 63 (89%) instances. None of the patients in this cohort required subsequent surgical decortication. Conclusions: The use of IPCs in lung transplant patients was associated with an infectious complication rate comparable to other populations previously studied. A high rate of auto‐pleurodesis was observed. This work suggests that IPCs may be considered for the management of recurrent pleural effusions in lung allograft recipients. [ABSTRACT FROM AUTHOR]